Cost-effectiveness of schizophrenia pharmacotherapy.
Soumerai
Stephen B
SB
Law
Michael R
MR
D014150:Antipsychotic Agents / Q000191:economics* / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D016527:Drug Costs / Q000706:statistics & numerical data; D006801:Humans; D010546:Perphenazine / Q000191:economics / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic / Q000592:standards; D012107:Research Design / Q000592:standards; D012559:Schizophrenia / Q000188:drug therapy* / Q000191:economics
D014150:Antipsychotic Agents; D010546:Perphenazine